David Kim, DPM
Podiatrist · Kingston, NYNPI 1396712030
Payments from drug & device makers
Across 48 payments — averaging $57.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Mimedx Group, Inc.$232
- KCI USA, Inc.$216
- Medtronic$138
- Linvatec Corporation$134
- Smith+Nephew$78
- plus $406 from 9 others
What the payments were for
- Food & beverage$2,749100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 18 | $1,545 |
| Mimedx Group, Inc. | 5 | $232 |
| KCI USA, Inc. | 2 | $216 |
| Medtronic | 1 | $138 |
| Linvatec Corporation | 1 | $134 |
| Smith+Nephew | 4 | $78 |
| Medartis Inc. | 1 | $78 |
| Paratek Pharmaceuticals, Inc. | 4 | $75 |
| Treace Medical Concepts, Inc. | 2 | $66 |
| Amgen(2 entities) | 4 | $66 |
| AbbVie | 2 | $51 |
| Organogenesis Inc. | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Advanced Oxygen Therapy Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DART-FIRE$334
- V.A.C. DERMATAC$187
- V.A.C. VERAFLO$187
- ORTHOLOC 3DI CROSSCHECK$167
- ORTHOLOC 3DI$163
- VARIAX$142
- INCEPTIV$138
- BioBrace 23mm$134
- CITREFIX$120
How this compares
$2,749 in reported general payments places this provider in the 80th percentile of 862 podiatrist providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 124 | $107,105 |
| Ciclopirox | 41 | $2,083 |
| CiclopiroxCiclopirox Olamine | 77 | $1,236 |
| Ammonium Lactate | 32 | $748 |
| Terbinafine Hcl | 63 | $444 |
| Gentamicin Sulfate | 12 | $378 |
| Mupirocin | 33 | $348 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $284 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $216 |
| Clindamycin Hcl | 13 | $115 |
| Silver Sulfadiazine | 13 | $112 |
| Methylprednisolone | 13 | $104 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $72 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Kingston
- Tracey TobackKingston$8K
- Daniel LongoKingston$6K
- Christopher BromleyPoughkeepsie$152K
- Scott GawlikBrooklyn$77K
- Waldemar MajdanskiAstoria$71K
- Michael HutzelSeaford$64K
- Donald RubinCorning$53K
- Steven NormanMiddle Village$42K
- Elvis DanneNew York$35K
- Adam CirlincioneGlen Cove$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.